CEDARVILLE, Ohio — The state of Ohio has introduced a breakthrough in its effort to fight the continuing COVID-19 pandemic.
Throughout his briefing on Thursday, Gov. Mike DeWine said that Ohio has entered right into a partnership with Abbott and eMed for the acquisition of two million at-home BinaxNow speedy antigen assessments that may be self-administered with leads to about 15 minutes.
The assessments shall be made obtainable to the state’s native and county well being departments.
“Via an settlement with eMed to offer telehealth providers, a person who makes use of one in every of these assessments might be guided by a proctor and can get the leads to minutes, with out having to go to a testing location,” DeWine defined.
DeWine says the settlement will permit communities to extra aggressively take a look at for COVID-19 than at another time in the course of the pandemic. The $50 million funding utilizing CARES Act funding will assist make testing extra broadly obtainable, in line with the governor.
As we speak we’re asserting a brand new partnership involving Abbott and eMed to convey speedy, dependable testing into the house. Ohio will buy at the least 2M at-home BinaxNow #COVID19 speedy antigen assessments that may be self-administered with leads to about 15 minutes.
— Governor Mike DeWine (@GovMikeDeWine) January 21, 2021
You’ll be able to watch Gov. DeWine’s COVID-19 briefing from Thursday within the participant beneath: